US Broker Ratings

QuidelOrtho Corporation (QDEL) Stock Analysis: Unpacking a 25% Potential Upside

For investors seeking opportunities in the healthcare sector, QuidelOrtho Corporation (NASDAQ: QDEL) presents an intriguing case with its diagnostic testing solutions that span multiple business units,..

Amicus Therapeutics, Inc. (FOLD): Investor Outlook with 3.86% Potential Upside

Amicus Therapeutics, Inc. (NASDAQ: FOLD) is making waves in the biotechnology sector with its strategic focus on rare diseases, a niche that offers both challenges and..

Schrodinger, Inc. (SDGR) Stock Analysis: Unveiling a 47% Upside Potential Amidst Robust Revenue Growth

Schrodinger, Inc. (NASDAQ: SDGR) stands as a beacon of innovation in the healthcare sector, specifically within the health information services industry. With a market capitalization of..

Novavax, Inc. (NVAX) Stock Analysis: Exploring a 76% Potential Upside in the Biotechnology Sector

Novavax, Inc. (NVAX) is a name that has been on the radar for investors interested in the biotechnology sector, especially those focused on vaccine development. With..

Dyne Therapeutics, Inc. (DYN) Stock Analysis: A Closer Look at its 113% Upside Potential

Dyne Therapeutics, Inc. (NASDAQ: DYN), a clinical-stage biotechnology firm, is capturing investor attention with an impressive potential upside of 113.25%. Specializing in therapeutics for neuromuscular diseases,..

Beam Therapeutics Inc. (BEAM) Investor Outlook: Navigating Biotech with a 71% Upside Potential

Investors eyeing opportunities in the biotech sector may find Beam Therapeutics Inc. (BEAM) a compelling case, especially given its potential upside of 71.12%. This Massachusetts-based company,..

CG Oncology, Inc. (CGON) Investor Outlook: Exploring the 76.61% Potential Upside in Cutting-Edge Bladder Cancer Therapies

CG Oncology, Inc. (NASDAQ: CGON) is making waves in the biotechnology sector with its innovative approach to bladder cancer treatment. Based in Irvine, California, this late-stage..

Addus HomeCare Corporation (ADUS) Stock Analysis: Exploring a 29% Potential Upside in the Healthcare Sector

Investors seeking opportunities in the healthcare sector might find Addus HomeCare Corporation (NASDAQ: ADUS) a compelling consideration. This Frisco, Texas-based company, with a market cap of..

Artivion, Inc. (AORT) Growth Potential: Analyst Ratings Show 15.98% Upside for Medical Device Innovator

Artivion, Inc. (NASDAQ: AORT), a prominent player in the healthcare sector, specifically within the medical devices industry, has been capturing investor attention with its impressive growth..

Kestra Medical Technologies (KMTS) Stock Analysis: Strong Revenue Growth and 19% Potential Upside

Investors have been increasingly eyeing Kestra Medical Technologies, Ltd. (KMTS), a burgeoning player in the healthcare sector specializing in medical instruments and supplies. With its current..

UFP Technologies, Inc. (UFPT) Stock Analysis: Exploring a 38.85% Potential Upside in the Medical Device Sector

UFP Technologies, Inc. (NASDAQ: UFPT) is a noteworthy player in the healthcare sector, specifically within the medical devices industry. With its headquarters in Newburyport, Massachusetts, the..

ARS Pharmaceuticals, Inc. (SPRY): Investor Outlook Reveals a Compelling 162% Upside Potential

ARS Pharmaceuticals, Inc. (NASDAQ: SPRY), a promising player in the biotechnology sector, has captured investor attention with a standout potential upside of 162.84%. As a biopharmaceutical..

Acadia Healthcare (ACHC) Stock Analysis: Unveiling a 48.56% Potential Upside

Acadia Healthcare Company, Inc. (NASDAQ: ACHC), a prominent player in the U.S. healthcare sector, specifically in the medical care facilities industry, is catching the attention of..

Vericel Corporation (VCEL) Stock Analysis: Exploring a 48% Potential Upside in the Biotech Sector

Vericel Corporation (NASDAQ: VCEL), a prominent player in the biotechnology sector, stands out with a substantial potential upside of 48.33%. As a commercial-stage biopharmaceutical company, Vericel..

MannKind Corporation (MNKD) Stock Analysis: Unveiling a 71% Upside Potential with Strong Buy Ratings

MannKind Corporation (NASDAQ: MNKD), a prominent player in the biotechnology sector, has caught the attention of investors with a compelling growth narrative and significant upside potential...

GeneDx Holdings Corp. (WGS) Investor Outlook: Robust Growth Potential with a 29.95% Upside

GeneDx Holdings Corp. (NASDAQ: WGS), a prominent player in the healthcare sector, is generating significant buzz among investors due to its impressive growth trajectory and the..

Protagonist Therapeutics, Inc. (PTGX) Stock Analysis: Exploring a 14.44% Potential Upside in the Biotech Sector

Protagonist Therapeutics, Inc. (PTGX), a promising player in the biotechnology sector, is capturing investor attention with its innovative pipeline and significant market potential. Headquartered in Newark,..

Liquidia Corporation (LQDA) Stock Analysis: Unveiling a 36.86% Potential Upside in the Biotechnology Sector

Liquidia Corporation (NASDAQ: LQDA) is making waves in the biotechnology sector, capturing the attention of investors with a staggering 36.86% potential upside. Based in Morrisville, North..

ICU Medical, Inc. (ICUI) Stock Analysis: Exploring a 25% Upside Potential with Strong Buy Ratings

ICU Medical, Inc. (NASDAQ: ICUI), a key player in the healthcare sector specializing in medical instruments and supplies, has caught the attention of investors with its..

Merus N.V. (MRUS) Stock Analysis: Exploring a 7.78% Potential Upside Amid Biotech Innovations

Merus N.V. (NASDAQ: MRUS), a Netherlands-based clinical-stage biotechnology company, has been capturing attention in the healthcare sector with its innovative approach to antibody therapeutics. Operating at..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds